MMP9 and chronic obstructive pulmonary disease: Some studies have shown the increased expression and activity of MMP9 and MMP2 in the sputum, bronchoalveolar lavage fluid and peripheral blood from patients with COPD, and MMP9 and MMP2 may contribute to the severity of airflow limitation during COPD progression [9], [10].